Eagle Pharmaceuticals, Inc. Royalty Expense
Eagle Pharmaceuticals, Inc. reported Royalty Expense of $0 for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. royalty expense for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. royalty expense for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Eagle Pharmaceuticals, Inc. royalty expense for the quarter ending 2022-12-31 was $1.62M, a 37.92% decline year-over-year.
- Eagle Pharmaceuticals, Inc. royalty expense for the quarter ending 2022-09-30 was $2.78M, a 0.32% increase year-over-year.
- Eagle Pharmaceuticals, Inc. royalty expense for fiscal 2022 was $9.48M, a 11.02% decline from fiscal 2021.
- Eagle Pharmaceuticals, Inc. royalty expense for fiscal 2021 was $10.65M, a 9.87% decline from fiscal 2020.
- Eagle Pharmaceuticals, Inc. royalty expense for fiscal 2020 was $11.82M, a 9.13% decline from fiscal 2019.
- Eagle Pharmaceuticals, Inc. royalty expense for fiscal 2019 was $13.01M, a 33.45% decline from fiscal 2018.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month | Royalty Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q/A · filed 2023-08-09 | $0.00 10-Q/A · filed 2023-08-09 | $1.62M derived: sum of 3 quarters · filed 2023-08-09 | $4.41M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $1.62M derived: sum of 2 quarters · filed 2023-05-09 | $4.41M derived: sum of 3 quarters · filed 2023-05-09 | $6.90M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $4.41M derived: sum of 2 quarters · filed 2023-03-23 | $6.90M derived: sum of 3 quarters · filed 2023-08-09 | $9.48M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $2.78M 10-Q · filed 2022-11-09 | $5.28M derived: sum of 2 quarters · filed 2023-08-09 | $7.85M 10-Q · filed 2022-11-09 | $10.47M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | $2.49M 10-Q/A · filed 2023-08-09 | $5.07M 10-Q/A · filed 2023-08-09 | $7.69M derived: sum of 3 quarters · filed 2023-08-09 | $10.46M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $2.58M 10-Q · filed 2023-05-09 | $5.20M derived: sum of 2 quarters · filed 2023-05-09 | $7.97M derived: sum of 3 quarters · filed 2023-05-09 | $10.82M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $5.39M derived: sum of 2 quarters · filed 2023-03-23 | $8.24M derived: sum of 3 quarters · filed 2023-03-23 | $10.65M 10-K · filed 2023-03-23 | |
| 2021-09-30 | $2.77M 10-Q · filed 2022-11-09 | $5.62M derived: sum of 2 quarters · filed 2022-11-09 | $8.04M 10-Q · filed 2022-11-09 | $10.73M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2021-06-30 | $2.85M 10-Q · filed 2022-08-09 | $5.26M 10-Q · filed 2022-08-09 | $7.96M derived: sum of 3 quarters · filed 2023-03-23 | $11.22M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2021-03-31 | $2.41M 10-Q · filed 2022-05-09 | $5.11M derived: sum of 2 quarters · filed 2023-03-23 | $8.37M derived: sum of 3 quarters · filed 2023-03-23 | $11.19M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2020-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $5.96M derived: sum of 2 quarters · filed 2023-03-23 | $8.78M derived: sum of 3 quarters · filed 2023-03-23 | $11.82M 10-K · filed 2023-03-23 | |
| 2020-09-30 | $3.26M 10-Q · filed 2021-11-09 | $6.08M derived: sum of 2 quarters · filed 2021-11-09 | $9.12M 10-Q · filed 2021-11-09 | $12.69M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | $2.82M 10-Q · filed 2021-08-09 | $5.86M 10-Q · filed 2021-08-09 | $9.43M derived: sum of 3 quarters · filed 2022-03-08 | $12.21M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | $3.04M 10-Q · filed 2021-05-10 | $6.60M derived: sum of 2 quarters · filed 2022-03-08 | $9.39M derived: sum of 3 quarters · filed 2022-03-08 | $12.50M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $6.35M derived: sum of 2 quarters · filed 2022-03-08 | $9.46M derived: sum of 3 quarters · filed 2022-03-08 | $13.01M 10-K · filed 2022-03-08 | |
| 2019-09-30 | $2.79M 10-Q · filed 2020-11-02 | $5.89M derived: sum of 2 quarters · filed 2020-11-02 | $9.44M 10-Q · filed 2020-11-02 | $15.54M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2019-06-30 | $3.11M 10-Q · filed 2020-08-10 | $6.66M 10-Q · filed 2020-08-10 | $12.76M derived: sum of 3 quarters · filed 2021-03-05 | $17.13M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2019-03-31 | $3.55M 10-Q · filed 2020-05-11 | $9.65M derived: sum of 2 quarters · filed 2021-03-05 | $14.02M derived: sum of 3 quarters · filed 2021-03-05 | $18.50M derived: sum of 4 quarters · filed 2021-03-05 | |
| 2018-12-31 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $10.47M derived: sum of 2 quarters · filed 2021-03-05 | $14.96M derived: sum of 3 quarters · filed 2021-03-05 | $19.54M 10-K · filed 2021-03-05 | |
| 2018-09-30 | $4.37M 10-Q · filed 2019-11-12 | $8.86M derived: sum of 2 quarters · filed 2019-11-12 | $13.44M 10-Q · filed 2019-11-12 | $17.92M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $4.49M 10-Q · filed 2019-08-08 | $9.07M 10-Q · filed 2019-08-08 | $13.55M derived: sum of 3 quarters · filed 2020-03-02 | $20.40M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $4.58M 10-Q · filed 2019-05-07 | $9.07M derived: sum of 2 quarters · filed 2020-03-02 | $15.92M derived: sum of 3 quarters · filed 2020-03-02 | $20.83M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $4.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $11.33M derived: sum of 2 quarters · filed 2020-03-02 | $16.24M derived: sum of 3 quarters · filed 2020-03-02 | $23.47M 10-K · filed 2020-03-02 | |
| 2017-09-30 | $6.85M 10-Q · filed 2018-11-01 | $11.76M derived: sum of 2 quarters · filed 2018-11-01 | $18.99M 10-Q · filed 2018-11-01 | $27.97M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-06-30 | $4.91M 10-Q · filed 2018-08-07 | $12.14M 10-Q · filed 2018-08-07 | $21.12M derived: sum of 3 quarters · filed 2019-02-28 | $25.55M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2017-03-31 | $7.23M 10-Q · filed 2018-05-10 | $16.21M derived: sum of 2 quarters · filed 2019-02-28 | $20.64M derived: sum of 3 quarters · filed 2019-02-28 | $24.93M derived: sum of 4 quarters · filed 2019-02-28 | |
| 2016-12-31 | $8.98M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $13.41M derived: sum of 2 quarters · filed 2019-02-28 | $17.70M derived: sum of 3 quarters · filed 2019-02-28 | $19.52M 10-K · filed 2019-02-28 | $20.99M 10-K · filed 2017-03-15 |
| 2016-09-30 | $4.42M 10-Q · filed 2017-11-08 | $8.72M derived: sum of 2 quarters · filed 2017-11-08 | $10.54M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $4.29M 10-Q · filed 2017-08-09 | $6.11M 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | $1.82M 10-Q · filed 2017-05-08 | ||||
| 2015-12-31 | $7.88M 10-K · filed 2018-02-26 | ||||
| 2014-12-31 | $2.71M 10-K · filed 2017-03-15 | ||||
| 2014-09-30 | $6.67M 10-K · filed 2017-03-15 | ||||
| 2013-12-31 | $1.95M 10-K · filed 2017-03-15 |